C
COGNITION THERAPEUTICS INC
NASDAQ: CGTX (Cognition Therapeutics, Inc.)
最近更新时间: 2小时之前1.66
-0.03 (-1.78%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Cognition Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.00 |
|
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.81% |
| 机构持股比例 | 18.87% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bios Capital Management, Lp | 30 Jun 2025 | 6,000,000 |
| Davenport & Co Llc | 30 Sep 2025 | 2,689,336 |
| Acadian Asset Management Llc | 30 Jun 2025 | 701,940 |
| Chescapmanager Llc | 30 Jun 2025 | 503,259 |
| Voss Capital, Lp | 30 Jun 2025 | 450,000 |
| Cm Management, Llc | 30 Jun 2025 | 250,000 |
| Kestra Advisory Services, Llc | 30 Jun 2025 | 155,934 |
| Sigma Planning Corp | 30 Jun 2025 | 147,990 |
| Mcadam, Llc | 30 Sep 2025 | 72,075 |
| 52周波幅 | ||
| 中 | 4.00 (140.96%) | |
| 总计 | 1 购买 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Chardan Capital | 08 Aug 2025 | 4.00 (140.96%) | 购买 | 0.755 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合